|
- Drugs (psychoactive) - World Health Organization (WHO)
The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important
- WHO Drug Information
About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers Launched in 1987, WHO Drug Information communicates the latest international news and trends to regulatory agencies, academic and training institutions, researchers
- Alcohol, Drugs and Addictive Behaviours
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours
- Anatomical Therapeutic Chemical (ATC) Classification
In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties Drugs are classified in groups at five different levels
- WHO updates guidelines on opioid dependence treatment and overdose . . .
WHO announces development of updated guidelines for the psychosocially assisted pharmacological treatment of opioid dependence and community management of opioid overdoseIn 2022, approximately 60 million people globally engaged in non-medical opioid use, including the use of drugs like heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances Their regular non
- WHO announces landmark changes in treatment of drug-resistant tuberculosis
The World Health Organization (WHO) today released its Consolidated guidelines on tuberculosis (TB)- Module 4: treatment and care, consolidating all previous guidelines into a single comprehensive document and introducing significant improvements in treatment options for people with multidrug-resistant or rifampicin-resistant tuberculosis (MDR RR-TB)
- WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Module 4: treatment and care encompass all current recommendations for managing drug-susceptible and drug-resistant TB, alongside patient care and support strategies Developed according to WHO’s rigorous standards, the guidelines rely on the latest evidence reviews and the GRADE methodology to evaluate evidence quality and determine the strength of each recommendation Primarily aimed at
- Expert Committee on Drug Dependence (ECDD)
Expert Committee on Drug Dependence ECDD is a scientific advisory body to WHO that consists of an independent group of experts in the field of drugs and medicines and drug dependence liability
|
|
|